期刊文献+

重度子痫前期患者血浆凝血、纤溶相关因子水平变化的意义 被引量:2

The changes of coagulant and fibrinolytic factors in plasma of patients with severe preeclampsia
下载PDF
导出
摘要 目的:探讨凝血相关因子在重度子痫前期患者外周血病理性高凝状态发病机制中的作用。方法:采用ELISA方法测定30例重度子痫前期孕妇(子痫前期组)及42例正常晚期妊娠孕妇(正常妊娠组)外周血凝血相关因子的浓度,包括TF、TFPI、t-PA、PAI-1和PAI-2,并进行对比分析。结果:两组孕妇的年龄、孕周无显著性差异;重度子痫前期组患者的D-二聚体浓度及FDP阳性率均显著高于对照组而血小板计数则显著低于对照组。子痫前期组的血浆TF浓度为(53.02±8.64)pg/ml显著高于对照组的(30.84±9.04)pg/ml,TFPI浓度为(3.04±1.08)ng/ml则显著低于对照组的(5.13±0.93)ng/ml(P<0.01);子痫前期组的t-PA浓度为(42.03±16.08)ng/ml显著低于对照组的(67.12±18.91)ng/ml(P<0.01);子痫前期组PAI-1、PAI-2的浓度分别为(81.37±14.87)ng/ml、(469.14±29.20)ng/ml均显著高于对照组的(63.15±8.88)ng/ml和(122.56±17.67)ng/ml。结论:重度子痫前期患者的病理性高凝血状态和凝血相关因子的平衡失调有关,内皮细胞的损伤或激活、胎盘表达凝血相关因子异常可能是重要原因。 Objective: To explore the pathogenesis of thrombophilia in severe preeclampsia patients. Methods: 30 cases of severe preeclampsia patient's (study group) and 42 cases of normal late pregnant women's (control group) plasma levels of tissue factor (TF), tissue factor pathway inhibitor (TFPI), tissue - type plasminogen ativator ( t - PA), plasminogen activator inhibitor - 1 (PAI - 1 ), and plasminogen activator inhibitor - 2 (PAI - 2) were measured by ELLISA. Results: There were no significant difference in gestational age and pregnant women'age between two groups. The plasma D - dimer levels in severe preeclampsia group were significant higher than control group, and so as the positive rates of FDP between two groups. The TF level (53. 02 ± 8. 64) pg/ml in study group was significant higher than the level ( 30. 84 ± 9. 04 ) pg/ml in control group ( P 〈 0. 01 ). However TFPI level ( 3.04 ± 1.08 ) ng/ml in study group was significant lower than the level (5. 13 ± 0. 93 ) ng/ml in control group ( P 〈 0. 01 ) . The plasma levels of t - PA in study group and control group were (42. 03 ±16. 08) ng/ml and (67. 12 ± 18. 91 ) ng/ml respectively, there was significant difference between two groups. Both PAI- 1 plasma level (81.37 ± 14. 87) ng/ml and PAI-2 plasma level (469. 14 ±29. 20) ng/ml in severe preeelampsia patients were significant higher than PAI- 1 plasma level (63. 15 ± 8. 88) ng/ml and PAI- 2 level (122. 56 ± 17. 67) ng/ml in control group (P 〈0. 01 ) . Conclusion:The thrombophilia in severe preeclampsia patients is associated with imbalance of plasma coagulation factors, vascular endothelial cells activation or damage and abnormal expression of coagulation factors in placenta may be the main cause.
出处 《中国妇幼保健》 CAS 北大核心 2008年第22期3080-3082,共3页 Maternal and Child Health Care of China
基金 上海市浦东新区社发局卫生科技项目(PW2005D-04)
关键词 重度子痫前期 高凝状态 凝血因子 Severe preeclampsia Thrombophilia Coagulation factors
  • 相关文献

参考文献10

  • 1Mello G, Parretti E, Marozlo L et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large - scale, case - controlledstudy. Hypertension, 2005, 46 : 1270
  • 2林其德.子癎前期及子的病因学研究进展[J].中国实用妇科与产科杂志,2006,22(1):3-5. 被引量:29
  • 3Pedersen B, Holscher T, Sato Y et al. A balance between tissue factor and tissue factor pathway inhibitor is requircd for embryonic development and hemostasis in adult mice. Blood , 2005, 105:2777
  • 4Rabiet M J, Plantier JL, Dejana E. Thrombin - induced endothelial cell dysfunction. Br Med Bull, 1992, 50:936
  • 5Perry KG, Martin JN. Abnormal hemostasis and coagulopathy in preeclampsia and eclamsia. Clin Obstet Gynecol, 1992, 35:338
  • 6Lanir N, Aharon A, Brenner B. Haemostastic mechanisms in human placenta. Best Prect Res Clin Haemotol, 2003, 16 (2) : 183
  • 7Aharen A, Brenner B, Katz T et al. tissue factor and tissue factor pathway inhibitor levels in trophoblast cells : implications for placental hemostasis, Thromb Haemost, 2004, 92 (2): 776
  • 8Neale D, Caze R, Small M et al. first trimester trophoblast exposed to the sera of women with preeclampsia have increased secretion of tissue factor. Am J Obstet Gynecol, 2005, 193 (6, suppl) : S13
  • 9Bar J, Mashiah R, Cohen - Saeher B et al. effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Thrombosis Reseach, 2002, 102 : 235
  • 10Bellart J, Gilbert R, Angles A et al.Tissue factor levels and high ration of fibrlnopeptide A: D - dimer as a measure of endothelial procoagulant disorder in preeclampsia. Br J Obstet Gyneacol, 1999, 106 : 594

二级参考文献12

共引文献28

同被引文献16

  • 1林其德.子癎前期及子的病因学研究进展[J].中国实用妇科与产科杂志,2006,22(1):3-5. 被引量:29
  • 2陈婷,张丽娟,贺达仁.妊娠期高血压疾病高凝状态的研究[J].医学与哲学(B),2006,27(4):30-31. 被引量:1
  • 3Pritchard JA, Cunningham FG, Pritchard SA. The Parklancl Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases [J]. Am J Obstet Gynecol,1984,148(7) :951 -9631.
  • 4Dadak C, Ulrich W, Sinzinger H. Morphological changes in the umbilical arteries of babies born to pre - eclamptic mothers : an ultrastucturai study [ J ]. Placenta, 1984,5 ( 5 ) :419 - 426.
  • 5Rabiet MJ, Plantier JI, Dejana E. Thrombin - induced endothelial cell dysfunction [ J]. Br Med Bull, 1994,50 (4) :936 - 945.
  • 6Mello G, Parretti E, Marozio L, et al. Thrombophilia is significantly associated with severe preeclampsia resalts of a large - scale, case - controlled study [ J ]. Hypertension ,2005,46 (6) : 1270 - 1274.
  • 7乐杰.妇产科学[M].第7版.北京:人民卫生出版社,2010:109.
  • 8Uchikova EH, Ledjev II. Changes in haemostasis during nor- mal pregnancy[J]. Eur J Obstet Gynecol Reprod Biol ,2005, 119(2):185-188.
  • 9Sibai B, Dekker G, Kupferminc M. Preeclampsia[J]. Lancet, 2005,365:785-99.
  • 10Herse F, Youpeng B, Staff AC, et al . Circulating and utero- placental adipocytokine concentrations in preeclampsia[J]. Reprod Sci ,2009,16(6) :584-590.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部